Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

David Yang

Has grant

Dana-Farber Cancer Institute

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Recent Grants

Grant: Open

ASTRO: Advancing Biomarker Discovery in Prostate Cancer Through Computer Vision-Driven Profiling of Tumor and Microenvironmental Heterogeneity

Open Date: 2026-10-01

Close Date: 2031-09-30

Articles (8)

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Collaborators (7)

Lucia Kwak

Johns Hopkins University

UNITED STATES

View details

Mahmut Akgul

Assistant Professor

Brigham and Women's Hospital

UNITED STATES

View details

Eddy Saad

Dana-Farber Cancer Institute

UNITED STATES

View details

Ruolin Liu

Broad Institute

UNITED STATES

View details

Daniel Abravanel

Dana-Farber Cancer Institute

UNITED STATES

View details

Luke Chen

Harvard University

UNITED STATES

View details

Atish Choudhury

Dana-Farber Cancer Institute

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

David Yang

Research Interests

Explore related searches

Recent Grants

Articles (8)

Immune Spatial Organization Predicts Distant Metastasis Risk in Aggressive Localized Prostate Cancer

A Phase II Study of Berzosertib in Combination with Carboplatin Compared with Docetaxel with Carboplatin in Metastatic Castration-Resistant Prostate Cancer

Impact of Cribriform Pattern on Progression-Free Survival After Radical Prostatectomy in Gleason Score 8-10 Prostate Cancer

Efficacy, safety, and predictive biomarkers of neoadjuvant nab-paclitaxel and pembrolizumab in hormone receptor-positive breast cancer: A randomized pilot trial

Novel biomarkers for guiding treatment for prostate cancer

Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer

Molecular Alterations Associated with Histologically Overt Stromal Response in Patients with Prostate Cancer

AI-derived Tumor Volume from Multiparametric MRI and Outcomes in Localized Prostate Cancer

Collaborators (7)

Lucia Kwak

Mahmut Akgul

Eddy Saad

Ruolin Liu

Daniel Abravanel

Luke Chen

Atish Choudhury

Make your next move.